Depigmentation in a Patient with Chronic Myeloid Leukemia during Chemotherapy with Dasatinib
- Author:
Yong Woo CHOI
1
;
Nuri NA
;
Joonsoo PARK
Author Information
1. Department of Dermatology, School of Medicine, Catholic University of Daegu, Daegu, Korea. magincia@cu.ac.kr
- Publication Type:Brief Communication
- Keywords:
Dasatinib;
Hypopigmentation;
Protein-tyrosine kinase
- MeSH:
Dasatinib;
Drug Therapy;
Humans;
Hypopigmentation;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;
Protein-Tyrosine Kinases
- From:Korean Journal of Dermatology
2019;57(5):292-293
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
